Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug ...

Rather, I was suggesting that he use the metaphor of promiscuous enzymes, a concept I’d learned from Andreas Wagner’s ...

Havas Health Network has launched Havas Life London, an evolution of Havas Life Medicom that is “deeply rooted” in the agency ...

Pfizer has shared positive results from a late-stage study of its Braftovi (encorafenib) combination in BRAF V600E-mutant ...

A new European survey sponsored by AstraZeneca (AZ) and Daiichi Sankyo has revealed widespread misconceptions about breast ...

AbbVie has partnered with Neomorph to develop new molecular glue degraders (MGDs) for multiple targets across oncology and ...

AstraZeneca (AZ) has received two separate recommendations from the National Institute for Health and Care Excellence (NICE) ...

Sanofi’s Sarclisa (isatuximab) has been approved by the European Commission (EC) to treat adults with newly diagnosed ...

There is a desire for the UK to create a science and technology superpower that will drive long-term economic growth. One way ...

Since the creation of the first social media site in 1997 [1], the use of various social media platforms has increased ...

The research published in Alzheimer’s and Dementia: Translational Research & Clinical Interventions found that certain ...

Iona Everson from PMGroup speaks to Amar Urhekar, CEO of Avalere Health, about his professional journey within healthcare ...